Skip to main content
Toggle navigation
Login
Search
Home
Back
Favorite
Like
Facebook
Tweet
General Session
Session V: Utilizing our Therapeutic Armamentarium: Right Patient/Right Drug
Friday, June 16, 2023
9:00 AM – 10:00 AM
.
Learning Objectives:
Understand the need and benefit of novel small molecule therapy in IBD
Incorporate JAK inhibitors in the management of patients with IBD
Interpret the safety data for novel targeted small molecule therapies for patients with IBD
Understand the indications and use of anti-TNF
Learn about when and how to use anti-integrin therapy
Summarize the potential role of IL inhibitors in the treatment of IBD
Evaluate key efficacy and safety data for interleukin (IL)-12/23 and IL-23p19 inhibitors for the management of IBD
Incorporate shared decision-making, consistent communication, and consideration of the patient perspective into the care strategy of patients with IBD